The main difference between a clinical trial and an expanded access program is that the intention of a clinical trial is to conduct research to test safety and efficacy of a new drug, while the intention of an expanded access program is for a physician to provide treatment to their patient with an unmet medical need. Both clinical trials and expanded access programs have eligibility criteria to determine who can participate.
However, the criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access a new drug via an expanded access program. Patients who enroll in expanded access programs are often the sickest patients who have exhausted other treatment options.
Andrea Enguita
20 Apr 2026
12 mins read
myTomorrows Team
16 Apr 2026
4 mins read
Stephanie Ferket
15 Apr 2026
15 mins read
myTomorrows Team
26 Mar 2026
5 mins read
Andrea Enguita
25 Mar 2026
8 mins read
Filippo Mandrini
19 Feb 2026
9 mins read
Andrea Enguita
14 Jan 2026
16 mins read
myTomorrows Team
15 Dec 2025
4 mins read
Daniël Groeneweg
27 Nov 2025
8 mins read